Position in ARVN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$217,181
+$56,008 QoQ
Shares Held
26,135
+71.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#109
of 198 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. ARVN ranks #149 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in ARVN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,181 | 26,135 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $161,173 | 15,205 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $238,599 | 20,118 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $167,009 | 19,602 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $111,297 | 15,122 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $215,015 | 30,629 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $231,036 | 12,052 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $362,331 | 14,711 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $424,695 | 15,954 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $446,195 | 10,809 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $208,310 | 5,061 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $247,819 | 9,071 | Shares | Sole | 2023-05-12 | |
| 2022-03-31 | $270,680 | 4,022 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $353,448 | 4,303 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $330,445 | 4,021 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $284,130 | 3,690 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $214,494 | 3,245 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $244,088 | 2,874 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||